FOXN3 and acute myeloid leukemia: Considering that FOXN3 expression in AML is low, quantification of PIM2 and E2F5 transcript levels in transformed AML cell lines with overexpression of FOXN3 is needed to further clarify the regulation of PIM2 and E2F5 by FOXN3 in AML.